I agree that this site is using cookies. You can find further informations here.
X
Garcia-Donas, Jesus
203  results:
Search for persons X
?
1

A machine learning approach to predicting ovarian cancer: I..:

Gómez-Talal, Ismael ; Barquín, Arantzazu ; Bote-Curiel, Luis...
Science Talks.  10 (2024)  - p. 100319 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pemigatinib in previously treated solid tumors with activat..:

Rodón, Jordi ; Damian, Silvia ; Furqan, Muhammad...
Nature Medicine.  30 (2024)  6 - p. 1645-1654 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Publisher Correction: Pemigatinib in previously treated sol..:

Rodón, Jordi ; Damian, Silvia ; Furqan, Muhammad...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
4

Proteomic profiles of peritoneal fluid-derived small extrac..:

Quiralte, Miguel ; Barquín, Arantzazu ; Yagüe-Fernández, Mónica...
Journal of Clinical Investigation.  134 (2024)  10 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
5

Randomized phase II clinical trial of ruxolitinib plus simv..:

Garcia-Donas, Jesus ; Martínez-Urbistondo, Diego ; Velázquez Kennedy, Kyra...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

Management of Fibroblast Growth Factor Inhibitor Treatment–..:

Siefker-Radtke, Arlene O. ; Necchi, Andrea ; Park, Se Hoon...
European Urology Open Science.  50 (2023)  - p. 1-9 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Open-label phase II clinical trial of ketoconazole as CYP17..:

Garcia-Donas, Jesus ; Hurtado, Alicia ; Garrigos, Laia...
Clinical and Translational Oncology.  25 (2023)  7 - p. 2090-2098 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Case–control study assessing the impact of COVID19 in advan..:

García-Donas, Jesús ; de Velasco, Guillermo ; Madurga, Rodrigo...
Clinical and Translational Oncology.  26 (2023)  3 - p. 732-738 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Predicting Ovarian Cancer with Machine Learning: Integratin..:

, In: 2023 31st European Signal Processing Conference (EUSIPCO),
Gomez-Talal, Ismael ; Barquin, Arantzazu ; Bote-Curiel, Luis... - p. 1160-1164 , 2023
Link: https://doi.org/10.23919..
 
?
10

MEK inhibitor sensitivity in BRAF fusion-driven prostate ca..:

Fenor, María Dolores ; Ruiz-Llorente, Sergio ; Rodríguez-Moreno, Juan Francisco...
Clinical and Translational Oncology.  24 (2022)  12 - p. 2432-2440 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Multivariate feature selection and autoencoder embeddings o..:

Bote-Curiel, Luis ; Ruiz-Llorente, Sergio ; Muñoz-Romero, Sergio...
Expert Systems with Applications.  206 (2022)  - p. 117865 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Logical Imputation to Optimize Prognostic Risk Classificati..:

Maurits, Jake S.F. ; van der Zanden, Loes F.M. ; Diekstra, Meta H.M....
Kidney Cancer.  6 (2022)  3 - p. 169-178 , 2022
Link: https://doi.org/10.3233/..
 
?
13

Molecular Biomarkers of Prognosis in Advanced Renal Cell Ca..:

García-del-Muro, Xavier ; Durán, Ignacio ; Perez-Gracia, Jose Luis...
Clinical Genitourinary Cancer.  20 (2022)  4 - p. 388.e1-388.e10 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Epithelial-to-Mesenchymal Transition Mediates Resistance to..:

Font, Albert ; Ruiz de Porras, Vicenç ; Valderrama, Begoña P....
Cancers.  13 (2021)  24 - p. 6235 , 2021
Link: https://doi.org/10.3390/..
 
?
15

MCM3 is a novel proliferation marker associated with longer..:

Kang, Eun Young ; Millstein, Joshua ; Popovic, Gordana...
Virchows Archiv.  480 (2021)  4 - p. 855-871 , 2021
Link: https://doi.org/10.1007/..
 
1-15